We are live on ! Find out more
FM

Family Management Portfolio holdings

AUM $834M
1-Year Est. Return 20.83%
This Fund
S&P 500
This Quarter Est. Return
+4.1%
1 Year Est. Return
+20.83%
3 Year Est. Return
+58.52%
5 Year Est. Return
+62.81%
10 Year Est. Return
+272.93%
AUM
$146M
AUM Growth
-$30.7M
Cap. Flow
-$35M
Cap. Flow %
-23.97%
Top 10 Hldgs %
47.65%
Holding
85
New
8
Increased
7
Reduced
34
Closed
17

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$2.78M
2
AMZN icon
Amazon
AMZN
+$1.86M
3
AXP icon
American Express
AXP
+$1.65M
4
HWM icon
Howmet Aerospace
HWM
+$1.39M
5
C icon
Citigroup
C
+$763K

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$7.02M
2
GD icon
General Dynamics
GD
+$5.45M
3
HRL icon
Hormel Foods
HRL
+$3.93M
4
BMY icon
Bristol-Myers Squibb
BMY
+$3.69M
5
FMC icon
FMC
FMC
+$2.37M

Sector Composition

Rank Sector Weight
1 Technology 21.94%
2 Healthcare 12.54%
3 Communication Services 11.48%
4 Consumer Discretionary 11.08%
5 Industrials 10.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DIS icon
51
Walt Disney
DIS
$169B
$281K 0.19%
2,694
ET icon
52
Energy Transfer Partners
ET
$69.8B
$270K 0.18%
14,000
TEVA icon
53
Teva Pharmaceuticals
TEVA
$39.6B
$263K 0.18%
7,250
PFE icon
54
Pfizer
PFE
$142B
$258K 0.18%
8,387
BMRN icon
55
BioMarin Pharmaceuticals
BMRN
$11.6B
$249K 0.17%
3,000
BRK.A icon
56
Berkshire Hathaway Class A
BRK.A
$1.1T
$244K 0.17%
1
SYK icon
57
Stryker
SYK
$130B
$240K 0.16%
2,000
WES
58
DELISTED
Western Gas Partners Lp
WES
$223K 0.15%
3,800
GOOG icon
59
Alphabet (Google) Class C
GOOG
$4.57T
$204K 0.14%
5,280
-360
-6% -$14K
XPLR
60
DELISTED
Xplore Technologies Corp.
XPLR
$180K 0.12%
89,109
SGYP
61
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$97K 0.07%
+16,000
New +$83.6K
MACK
62
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$88K 0.06%
2,733
+572
+26% +$24.4K
PGNX
63
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$86K 0.06%
10,000
IMDX
64
Insight Molecular Diagnostics
IMDX
$165M
$84K 0.06%
+598
New +$65.8K
GAB icon
65
Gabelli Equity Trust
GAB
$1.77B
$69K 0.05%
+12,818
New +$67.9K
AST
66
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$55K 0.04%
+12,008
New +$49.5K
GERN icon
67
Geron
GERN
$815M
$52K 0.04%
25,200
DVAX
68
DELISTED
Dynavax Technologies
DVAX
$43K 0.03%
+11,000
New +$80.6K
AAL icon
69
American Airlines Group
AAL
$10.6B
-25,300
Closed -$926K
ABBV icon
70
AbbVie
ABBV
$434B
-111,278
Closed -$7.02M
EL icon
71
Estee Lauder
EL
$30.4B
-16,935
Closed -$1.5M
FMC icon
72
FMC
FMC
$1.3B
-56,555
Closed -$2.37M
GD icon
73
General Dynamics
GD
$104B
-35,135
Closed -$5.45M
HIG icon
74
Hartford Financial Services
HIG
$39.1B
-54,250
Closed -$2.32M
HRL icon
75
Hormel Foods
HRL
$13.8B
-103,600
Closed -$3.93M

Similar funds

Family Management's Q4 2016 Portfolio in Review

As of Q4 2016, Family Management held 85 positions worth $146M, down 17% from $177M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Family Management withdrew a net $35M in Q4 2016, closing 17 positions and reducing 34 holdings. Its most notable exit was AbbVie, an estimated $7.02M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 19% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, Family Management opened a new position in American Express worth $1.77M.

  • Family Management's largest Q4 2016 buy was American Express: 23,871 shares worth $1.77M.
  • Family Management added most to ExxonMobil in Q4 2016, an estimated $2.78M increase.
  • Family Management's biggest Q4 2016 reduction was Bristol-Myers Squibb, cutting an estimated $3.69M.
  • Family Management fully exited AbbVie in Q4 2016, selling an estimated $7.02M.
  • Family Management's ten largest holdings make up 48% of its $146M portfolio in Q4 2016.
  • Family Management opened 8 new positions and closed 17 in Q4 2016.
  • Family Management's portfolio value fell 17% quarter-over-quarter to $146M.

Based on Family Management's 13F filing for Q4 2016, filed 10 Feb 2017.